This year, a wide range of session topics will be offered looking at the impact of biotechnology on our lives and examinations of how the industry is changing and evolving in the current market climate:
Tissue and skin regeneration, Australian innovation creating hope and options for millions
A lack of treatment options has left burn victims to suffer from unstoppable scarring and constant pain. At the same time doctors have been unable to help people living with diabetes or the elderly from developing wounds that become easily infected. Now Australian researchers are leading the way in developing new technologies for tissue regeneration to halt what has been described by one session speaker as a “silent epidemic.” Speakers will describe work being done in the Asia Pacific region to develop synthetic skin or to stimulate existing skin cells to heal more quickly.
Food security and uncertain supplies, how biotechnology could eradicate famine and reduce our reliance on toxic pesticides
Many around the world are stunned to hear about fellow humans who continue to suffer from famine and mass starvation in this modern age. Australia’s biotechnology researchers are looking for solutions. As populations grow and temperatures rise, there will be a fast-growing need for more resilient crops and more productive animals. Speakers at AusBiotech will discuss the challenge of doubling food production in the next 30 years to avoid severe shortages, even in developed countries.
Australia's biotechnology industry, maturing out of a financial crisis: Various sessions will look at how the global financial crisis actually aided Australia’s biotechnology industry. Companies were forced to focus on the most promising treatments and innovations. This has meant that many of Australia’s biotech companies have entered the final stages of development much faster than originally planned.
For Investors:
This year’s AusBiotech conference will also once again host the annual Australasian Life Sciences Investment Summit. Investors from around the world will attend short presentations by 40 of the most promising biotechnology companies. For the full speaker list, or to register, please visit http://www.ausbiotech2011.com.au/
AusBiotech 2011 is supported through the generous contributions of BioInnovation SA and the South Australian Government. Media passes are available on request.
About AusBiotech
AusBiotech is Australia’s voice on biotechnology, and represents more than 3,000 members, encompassing medicines, medical diagnostics and devices, agriculture, alternative fuels and climate change.
ENDS
Media enquiries:
Erik Denison
edenison@bcg.com.au
P: +61 (0) 29237 2800
M: +61 (0) 432 712 278
Lorraine Chiroiu
AusBiotech’s Communications Manager
lchiroiu@ausbiotech.org
P: +61 (0) 39828 1414
M: +61 (0) 429 801 118
